Author Question: Arm & Hammer markets a variety of deodorants, including Ultramax Confidence Dry Spray, ... (Read 137 times)

shofmannx20

  • Hero Member
  • *****
  • Posts: 562
Arm & Hammer markets a variety of deodorants, including Ultramax Confidence Dry Spray, Essentials Solid Deodorant, Ultramax Gel Antiperspirant, and several others. These deodorants would be considered a:
 A) marketing mix.
  B) product mix.
  C) target market.
  D) product line.
  E) brand mix.

Question 2

Marquez is interested in starting his own business. He is concerned about how much it will cost to start maintain this new venture. Which question should Marquez ask himself?
 A) Which ownership structure will minimize the tax burden for the company and for me?
  B) How risky is this business?
  C) Is this really a business or just a money-making hobby?
  D) Will the business have additional owners or investors in the future?
  E) How will day-to-day management decisions be made?



ciecieme

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

D

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library